NDC 65084-474

Canasa

Mesalamine

Canasa is a Rectal Suppository in the Human Prescription Drug category. It is labeled and distributed by Mckesson Rxpak Inc. The primary component is Mesalamine.

Product ID65084-474_f22429d1-5a9e-4286-a856-8104e188e35e
NDC65084-474
Product TypeHuman Prescription Drug
Proprietary NameCanasa
Generic NameMesalamine
Dosage FormSuppository
Route of AdministrationRECTAL
Marketing Start Date2001-01-05
Marketing CategoryNDA / NDA
Application NumberNDA021252
Labeler NameMckesson Rxpak Inc
Substance NameMESALAMINE
Active Ingredient Strength1000 mg/1
Pharm ClassesAminosalicylate [EPC],Aminosalicylic Acids [CS]
NDC Exclude FlagN
Listing Certified Through2019-12-31

Packaging

NDC 65084-474-14

30 SUPPOSITORY in 1 BOX (65084-474-14)
Marketing Start Date2016-01-20
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 65084-474-14 [65084047414]

Canasa SUPPOSITORY
Marketing CategoryNDA
Application NumberNDA021252
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2016-01-20
Marketing End Date2019-09-01

Drug Details

Active Ingredients

IngredientStrength
MESALAMINE1000 mg/1

OpenFDA Data

SPL SET ID:75fb1efa-d513-4203-8962-6508a24ef3eb
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 583257
  • 248420
  • Pharmacological Class

    • Aminosalicylate [EPC]
    • Aminosalicylic Acids [CS]

    NDC Crossover Matching brand name "Canasa" or generic name "Mesalamine"

    NDCBrand NameGeneric Name
    58914-501CanasaCanasa
    65084-474CanasaCanasa
    0023-5901Asacol HDmesalamine
    0430-0783ASACOL HDmesalamine
    0023-5853Delzicolmesalamine
    0179-0142Lialdamesalamine
    0093-5907MesalamineMesalamine
    0093-9224mesalaminemesalamine
    0378-1375Mesalaminemesalamine
    0378-9230Mesalaminemesalamine
    0472-1915MesalamineMesalamine
    0037-0066Rowasamesalamine
    0037-0022sfRowasamesalamine

    Trademark Results [Canasa]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    CANASA
    CANASA
    76124724 2595613 Live/Registered
    APTALIS PHARMA US, INC.
    2000-09-08

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.